As used in the Pharmaceutical Supplemental Rebate Act: A. "authority" or "department" means the health care authority; B. "labeler" means a person that receives prescription drugs from a manufacturer or wholesaler and repackages those drugs for later retail sale and that has a labeler code from the federal food and drug administration; C. "manufacturer" means a manufacturer of prescription drugs as defined in 42 U.S.C. 1396r-8(k)(5), including a subsidiary or affiliate of a manufacturer; D. "medicaid" means the joint federal-state health coverage program pursuant to Title 19 or Title 21 of the federal Social Security Act; E. "participating retail pharmacy" means a retail pharmacy or other business licensed to dispense prescription drugs that participates in the state medicaid program; F. "secretary" means the secretary of health care authority; and G. "wholesaler" means a business licensed to distribute prescription drugs in the state. History: Laws 2002, ch. 105, § 2; 2024, ch. 39, § 90. Cross references. — For Titles XIX and XXI of the Social Security Act, see 42 U.S.C.S. §§ 1396 et seq. and 1397 et seq., respectively. The 2024 amendment, effective July 1, 2024, provided that references to "authority" or "department" in the Pharmaceutical Supplemental Rebate Act mean the health care authority, and made conforming amendments; in Subsection A, added "'authority' or" and after "means the" deleted "human services department" and added "health care authority"; and in Subsection F, after "secretary of" deleted "human services" and added "health care authority".
‹ Prev All New Mexico sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.